You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
新銳醫藥(06108.HK)建議實施股本重組

格隆匯6月6日丨新銳醫藥(06108.HK)公告,董事會建議實施股本重組,當中將涉及股份合併、股本削減及股份拆細。

建議股份合併的基準爲將公司股本中每十(10)股每股面值0.05港元的已發行及未發行現有股份合併爲公司股本中一(1)股每股面值0.50港元的合併股份。

緊隨股份合併生效後,股本削減將以下列方式進行:(i)公司已發行股本中因股份合併產生的任何零碎合併股份將被註銷;(ii)以每股當時已發行合併股份0.49港元爲限,透過註銷公司繳足股本,將每股當時已發行合併股份的面值由0.50港元削減至0.01港元,從而使得每股已發行合併股份於有關削減後成爲每股面值0.01港元的新股份;及(iii)股本削減產生的進賬將轉撥至實繳盈餘賬,以供董事會按適用法律及細則允許的任何董事會認爲合適的方式動用。

緊隨股本削減生效後,每股當時法定但未發行的合併股份將拆細爲五十(50)股每股面值0.01港元的新股份。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account